Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
GZcZNKhk8CXv3Fa5
Listen
